SENP1-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

SENP1-IN-1 

SENP1-IN-1 是特异性去 SUMO 化蛋白酶 SENP1 的抑制剂，详细请参考专利文献 CN110627860，化合物 29。SENP1-IN-1 被开发用于增强肿瘤放射敏感性。

SENP1-IN-1

SENP1-IN-1 Chemical Structure

CAS No. : 2416910-69-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement[1].

IC50 & Target

SENP1[1]
体外研究
(In Vitro)

SENP1-IN-1 may improve the sensitivity of tumor cells to irradiation[1].
SENP1-IN-1 (0.7-20 μM; 72 hours)has cytotoxic for Hella cells with an IC50 of >20μM[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: Hela cells
Concentration: 0.7 μM, 2.2 μM, 6.6 μM, 20 μM
Incubation Time: 72 hours
Result: IC50>20 μM

分子量

570.85

Formula

C35H58N2O4
CAS 号

2416910-69-3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Li, Yiliang, et al. Preparation of ursolic acid derivatives useful as SENP1 inhibitors and tumor radiosensitizer. CN110627860A.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务